Concert Pharmaceuticals, Inc.
(NASDAQ : CNCE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.06%171.110.7%$969.22m
ABBVAbbVie, Inc. 0.23%138.361.9%$829.91m
PFEPfizer Inc. 0.24%49.390.9%$827.10m
LLYEli Lilly & Co. -0.25%300.551.1%$744.28m
MRKMerck & Co., Inc. -0.16%87.270.7%$738.70m
BMYBristol-Myers Squibb Co. 0.04%72.151.0%$650.09m
SIGASIGA Technologies, Inc. 3.22%24.050.0%$426.14m
AZNAstraZeneca Plc -0.30%65.831.0%$380.31m
ALNYAlnylam Pharmaceuticals, Inc. 0.64%219.978.1%$242.80m
GSKGSK Plc 0.00%40.570.3%$217.86m
HZNPHorizon Therapeutics Plc 0.04%69.635.4%$197.87m
SGENSeagen Inc. 1.61%178.645.7%$191.78m
NVSNovartis AG 0.50%86.000.2%$174.26m
RGENRepligen Corp. 0.06%246.416.7%$155.84m
NVONovo Nordisk A/S -0.59%102.590.1%$151.99m

Company Profile

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.